Web Results

www.pacermonitor.com/public/case/24519302/METCALF_v_ASTRAZENECA_PHARMACEUTICALS_LP_et_al

6 days ago ... METCALF v. ASTRAZENECA PHARMACEUTICALS LP et al (2:18-cv-09218), New Jersey District Court, Filed: 05/14/2018 - PacerMonitor ...

www.pacermonitor.com/public/case/24519304/WILLIS_v_ASTRAZENECA_PHARMACEUTICALS_LP_et_al

6 days ago ... WILLIS v. ASTRAZENECA PHARMACEUTICALS LP et al (2:18-cv-09220), New Jersey District Court, Filed: 05/14/2018 - PacerMonitor Mobile ...

www.employmentlawdaily.com/index.php/news/twelve-months-of-additional-leave-not-a-reasonable-accommodation-at-least-in-this-case

Her ADA retaliation claim and wrongful discharge cause of action under Puerto Rico law failed as well (Delgado-Echevarria v. Astrazeneca Pharmaceutical, LP ...

law.justia.com/cases/federal/district-courts/new-jersey/njdce/2015

NICO ELECTRICAL CONTRACTOR, INC. et al v. CITY OF ... SUPERIOR COURT OF NEW JERSEY et al ... LIVINGSTON v. ..... ASTRAZENECA AB et al v. .... NOVARTIS PHARMACEUTICALS CORPORATION .... CUBESMART L.P. et al

www.law360.com/articles/887798/astrazeneca-prevails-in-trial-over-diabetes-drug-patent

Feb 3, 2017 ... A Delaware federal judge ruled Thursday that AstraZeneca's ... the entire record in this case, the substantial evidence in the record, the ... Kassandra M. Officer, John D. Livingstone, M. David Weingarten and ... The case is AstraZeneca AB v. Aurobindo Pharma Ltd. et al., case number 1:14-cv-00664, in the ...

jamanetwork.com/journals/jama/fullarticle/2088852

Jan 6, 2015 ... We used information on all people living with type 1 diabetes at any ..... from sanofi-aventis and Novartis Pharmaceuticals; costs for advisory ... grants from Boehringer Ingelheim; grants from AstraZeneca LP. ... Livingstone SJ, Looker HC , Hothersall EJ, et al. ... de Ferranti SD, de Boer IH, Fonseca V, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3906991

Dec 7, 2013 ... All patients gave written informed consent before study entry, and the study protocol ..... This study was designed and funded by AstraZeneca Pharmaceuticals, Macclesfield, ... Howell A, Robertson JFR, Quaresma Albano J, et al. ..... Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB, Hortobagyi GN.

onlinelibrary.wiley.com/doi/pdf/10.1111/dme.13256

Aug 31, 2016 ... change was +0.5 kg with IDegLira vs –1.0 kg with placebo [estimated treatment difference 1.48 kg (95% CI 0.90; 2.06); .... IDegLira in combination with sulphonylureas H. W. Rodbard et al. ... Ltd, Livingston, UK) performed laboratory analyses. ..... from AstraZeneca Pharmaceuticals LP, Biodel, Inc., Boeh-.

caselaw.findlaw.com/us-federal-circuit/1618266.html

Astrazeneca UK Limited, IPR Pharmaceuticals Inc., and Shionogi Seiyaku ... DC, Mary K. Ferguson, of Cambridge, MA, John D. Livingstone, of Atlanta, GA, Mary ... See Peter H. Jones et al., Comparison of the Efficacy and Safety of ...... and in AstraZeneca Pharms. LP v. Aurobindo Pharma Ltd., 2009 WL 483131, at *3 (D. Del.